[Safety and feasibility of outpatient management in relapsed/refractory lymphoma treated with pegfilgrastim after multi-agent salvage therapy: a single-center, open-label, non-randomized, prospective interventional study].
[Rinsho ketsueki] The Japanese journal of clinical hematology（2023）
关键词
relapsed/refractory lymphoma,pegfilgrastim,prospective interventional study,multi-agent,single-center,open-label,non-randomized
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要